Peptide-based therapeutics are becoming an increasingly important part of modern pharmaceutical research and development. Positioned between small-molecule drugs and biologic therapies, peptides offer high target specificity, flexible molecular design, and the potential to address biological pathways that are difficult to modulate with conventional

Peptides play an increasingly important role in pharmaceutical research, biotechnology, diagnostics, and therapeutic development. Their ability to interact selectively with biological targets makes them valuable tools for studying cellular processes, developing targeted therapies, and designing new biomolecules.

Peptide synthesis is an essential technology in modern biotechnology, pharmaceutical research, molecular biology, and drug discovery. From producing short peptides for laboratory experiments to manufacturing complex sequences for therapeutic development, the choice of synthesis method can significantly influence productivity, reproducibility, cost,

Peptides have become increasingly important in pharmaceutical research, biotechnology, diagnostics, and life science innovation. From early-stage drug discovery to preclinical development and commercial manufacturing, reliable access to high-quality peptides is essential for achieving consistent experimental results and accelerating research progre

Peptides can be produced through several different manufacturing strategies, but two major approaches are chemical peptide synthesis and recombinant peptide production.

Peptide synthesis can be performed using different chemical strategies, but two of the most established approaches are solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).

PeptiOrigin provides custom peptide synthesis services for peptides ranging from approximately 2 to 100+ amino acids, with purity levels up to 99%, specialized chemical modifications, peptide libraries, and production from research quantities through multigram and kilogram scale.